Federal Circuit Court of Appeals Appears Unlikely to Side With Cannabis Companies in Case Challenging Marijuana Prohibition

A federal appeals court on Thursday appeared poised to reject claims by several Massachusetts marijuana businesses that the longstanding federal prohibition on the drug is no longer constitutional, according to Reuters.

The businesses, represented by attorney David Boies, argued that the legal and legislative landscape surrounding marijuana has shifted significantly since the U.S. Supreme Court upheld the federal ban in 2005.

Boies told the three-judge panel of the 1st U.S. Circuit Court of Appeals in Boston that the original justification for the ban—rooted in Congress’s goal of eradicating marijuana nationwide—has effectively been abandoned. He pointed out that 38 states, including Massachusetts, now allow marijuana use for medical or recreational purposes. He also cited Congress’s actions since 2014 barring the U.S. Department of Justice from interfering with state medical marijuana programs and its 2010 approval of medical marijuana in Washington, D.C.

However, the judges seemed unconvinced that these developments undercut Congress’s authority to regulate marijuana under the Constitution’s Commerce Clause. U.S. Circuit Judge Julie Rikelman, a Biden appointee, noted that Congress’s broader objective remains unchanged: controlling the supply and demand of controlled substances. Chief U.S. Circuit Judge David Barron, appointed by Obama, questioned why specific legislative carve-outs, such as those shielding state medical marijuana programs, would indicate an intent to relinquish the federal ban entirely.

The case stems from a lawsuit filed by Massachusetts cannabis businesses, including Canna Provisions, delivery operator Gyasi Sellers, cultivator Wiseacre Farm, and multistate operator Verano Holdings. U.S. District Judge Mark Mastroianni previously dismissed the lawsuit, stating that only the Supreme Court could overturn its precedent in Gonzales v. Raich. In that 2005 decision, the high court upheld Congress’s authority to criminalize marijuana possession under the Controlled Substances Act, even in states where it is legal.

The plaintiffs argued that the reasoning in Raich has been undermined by recent developments. In 2021, Justice Clarence Thomas suggested the federal ban may no longer be “necessary or proper” in light of changes in marijuana policy. Additionally, the Justice Department has signaled a shift by moving to reclassify marijuana as a Schedule III drug, a decision expected to be reviewed in January.

The case, Canna Provisions Inc. v. Garland, could have far-reaching implications for the future of federal marijuana policy, though the judges’ questions suggested they remain skeptical of the plaintiffs’ arguments.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders